ES2049561A1 - Procedimiento para la obtencion de polimeros con actividad sobre el sistema hematopoyetico. - Google Patents

Procedimiento para la obtencion de polimeros con actividad sobre el sistema hematopoyetico.

Info

Publication number
ES2049561A1
ES2049561A1 ES9101063A ES9101063A ES2049561A1 ES 2049561 A1 ES2049561 A1 ES 2049561A1 ES 9101063 A ES9101063 A ES 9101063A ES 9101063 A ES9101063 A ES 9101063A ES 2049561 A1 ES2049561 A1 ES 2049561A1
Authority
ES
Spain
Prior art keywords
polymers
activity
hematopoietic system
obtaining
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES9101063A
Other languages
English (en)
Other versions
ES2049561B1 (es
Inventor
Taviel De Andrade Tuduri
Ranieri Pivel
Gomez-Pamo Guerrero
Gallego Real
Amurrio Guenchea
Roncero Bueren
Fernandez Maganto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industrial Farmaceutica Cantabria SA
Original Assignee
Laboratorios Andromaco SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Andromaco SA filed Critical Laboratorios Andromaco SA
Priority to ES09101063A priority Critical patent/ES2049561B1/es
Priority to NO92921583A priority patent/NO921583L/no
Priority to EP19920500045 priority patent/EP0511932A3/en
Priority to JP4151074A priority patent/JPH05178751A/ja
Publication of ES2049561A1 publication Critical patent/ES2049561A1/es
Application granted granted Critical
Publication of ES2049561B1 publication Critical patent/ES2049561B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0087Glucomannans or galactomannans; Tara or tara gum, i.e. D-mannose and D-galactose units, e.g. from Cesalpinia spinosa; Tamarind gum, i.e. D-galactose, D-glucose and D-xylose units, e.g. from Tamarindus indica; Gum Arabic, i.e. L-arabinose, L-rhamnose, D-galactose and D-glucuronic acid units, e.g. from Acacia Senegal or Acacia Seyal; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Emergency Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE POLIMEROS CON ACTIVIDAD SOBRE EL SISTEMA HEMATOPOYETICO. SE DESCRIBE UN PROCEDIMIENTO PARA LA OBTENCION DE POLIMEROS DE NATURALEZA POLISACARIDICA CON ACTIVIDAD SOBRE EL SISTEMA HEMATOPOYETICO, A PARTIR DE POLISACARIDOS POLICARBOXILADOS TALES COMO ACIDO ALGINICO, GOMA ARABIGA O TRAGACANTO DE DISTINTAS FUENTES BIOLOGICAS Y CONSISTENTE EN LA SONICACION DE LAS SUSPENSIONES ACUOSAS DEFINIDAS DE DICHOS POLIMEROS EN CONDICIONES DETERMINADAS DE AMPLITUD, FRECUENCIA, TIEMPO Y TEMPERATURA; PURIFICANDOSE LOS PRODUCTOS OBTENIDOS MEDIANTE DIALISIS EXHAUSTIVA Y OBTENIENDOSE EN FORMA SOLIDA MEDIANTE LIOFILIZACION O ATOMIZACION, ESTANDO DOTADOS ESTOS PRODUCTOS DE UNA ACCION SOBRE LA ACTIVIDAD DEL SISTEMA HEMATOPOYETICO. TIENE APLICACION EN LA INDUSTRIA FARMACEUTICA.
ES09101063A 1991-04-27 1991-04-27 Procedimiento para la obtencion de polimeros con actividad sobre el sistema hematopoyetico. Expired - Fee Related ES2049561B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES09101063A ES2049561B1 (es) 1991-04-27 1991-04-27 Procedimiento para la obtencion de polimeros con actividad sobre el sistema hematopoyetico.
NO92921583A NO921583L (no) 1991-04-27 1992-04-24 Fremgangsmaate til fremstilling av polymerer med virkning paa det hematopoietiske system
EP19920500045 EP0511932A3 (en) 1991-04-27 1992-04-24 Process for the obtaining of polymers with activity on the hematopoietic system
JP4151074A JPH05178751A (ja) 1991-04-27 1992-04-27 造血系に活性を有する重合体の製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09101063A ES2049561B1 (es) 1991-04-27 1991-04-27 Procedimiento para la obtencion de polimeros con actividad sobre el sistema hematopoyetico.

Publications (2)

Publication Number Publication Date
ES2049561A1 true ES2049561A1 (es) 1994-04-16
ES2049561B1 ES2049561B1 (es) 1994-12-16

Family

ID=8272221

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09101063A Expired - Fee Related ES2049561B1 (es) 1991-04-27 1991-04-27 Procedimiento para la obtencion de polimeros con actividad sobre el sistema hematopoyetico.

Country Status (4)

Country Link
EP (1) EP0511932A3 (es)
JP (1) JPH05178751A (es)
ES (1) ES2049561B1 (es)
NO (1) NO921583L (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646901A1 (de) * 1996-11-13 1998-05-14 Helmut Prof Dr Heusinger Verfahren zum Herstellen von Abbauprodukten polymerer Glycosaminoglycane mittels Ultraschall
WO2001000682A1 (en) * 1999-06-30 2001-01-04 Pharmagenesis, Inc. Hematopoietic arabinogalactan composition
KR100367722B1 (ko) * 2000-03-29 2003-01-14 윤의구 초음파 전처리와 열수 추출에의한 수용성 저분자 알긴산의제조방법
WO2002002607A2 (en) 2000-06-29 2002-01-10 Pharmagenesis, Inc. Acid-modified arabinogalactan protein composition
KR20020011842A (ko) * 2000-08-04 2002-02-09 박권필 해조류에서 알긴산 추출 방법
US20040170598A1 (en) * 2001-04-05 2004-09-02 Emilio Barragan Polysubstituted polycarboxylic phosphoamide biopolymers, methods for their production and uses of compositions derived therefrom
FR2891831A1 (fr) * 2005-10-11 2007-04-13 Ifremer Procede de depolymerisation de polysaccharides par ultasons
MY159317A (en) 2008-12-15 2016-12-30 Ecopharm Corp Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
US20230407016A1 (en) * 2020-09-22 2023-12-21 Rensselaer Polytechnic Institute Polysaccharide-including liquid material and its manufacturing method

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891620A (en) * 1974-01-04 1975-06-24 Mobil Oil Corp Modified natural gums
FR2503714A1 (fr) * 1981-04-10 1982-10-15 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
GB2116576A (en) * 1982-02-16 1983-09-28 Kaken Pharma Co Ltd A method for a specific depolymerization of a polysaccharide having a rod-like helical conformation
US4977250A (en) * 1986-11-21 1990-12-11 Aorca S.A. Process for controlled depolymerization of polysaccharides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5919121B2 (ja) * 1975-10-31 1984-05-02 タイトウ カブシキガイシヤ シンキノヤクリカツセイタトウブンカイブツノ セイゾウホウホウ
JPS59175436A (ja) * 1983-03-25 1984-10-04 Showa Sangyo Kk 低粘性血中コレステロ−ル値上昇抑制剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891620A (en) * 1974-01-04 1975-06-24 Mobil Oil Corp Modified natural gums
FR2503714A1 (fr) * 1981-04-10 1982-10-15 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
GB2116576A (en) * 1982-02-16 1983-09-28 Kaken Pharma Co Ltd A method for a specific depolymerization of a polysaccharide having a rod-like helical conformation
US4977250A (en) * 1986-11-21 1990-12-11 Aorca S.A. Process for controlled depolymerization of polysaccharides

Also Published As

Publication number Publication date
NO921583D0 (no) 1992-04-24
JPH05178751A (ja) 1993-07-20
EP0511932A3 (en) 1993-06-09
EP0511932A2 (en) 1992-11-04
NO921583L (no) 1992-10-28
ES2049561B1 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
HU9401329D0 (en) Process for producing microcapsules
ES2049561A1 (es) Procedimiento para la obtencion de polimeros con actividad sobre el sistema hematopoyetico.
DE3473402D1 (en) Fixing volatiles in an amorphous substrate and products therefrom
DE69634043D1 (de) Zirkuläres dna molekül mit einem abhängigen replikationsursprung, seine herstellungsverfahren und seine verwendung in der gentherapie
ATE194288T1 (de) Proanthocyanidinpolymere mit antivirales aktivität und deren herstellungsverfahren
DE3561472D1 (en) Process for the extraction of poly-beta-hydroxybutyrates with a solvent from an aqueous suspension of microorganisms
DE68914401D1 (de) Verfahren zur Herstellung von Dextrin enthaltenden faserigen Nahrungsprodukten.
DE68925002D1 (de) Verfahren zur Herstellung von optisch-aktiven alpha-substituierten organischen Säuren und Mikroorganismen und Enzyme, die dafür verwendet werden.
GR3033210T3 (en) Preparation of protein microspheres, films and coatings
FI102681B1 (fi) Menetelmä glykoproteiinin valmistamiseksi
FR2627773B1 (fr) Particules fines de polyorganosilsesquioxane et procede de production de ces particules
FI872169A0 (fi) Menetelmä ruokatorven limakalvon tulehdusta parantavasti vaikuttavan, suspension muodossa olevan sukralfaattituotteen valmistamiseksi
IL88370A0 (en) Process for the production of biodegradable microcapsules of water-soluble peptides and proteins,and microcapsules obtained by this process
DE68924579D1 (de) Verfahren zur Herstellung von Polymer-Partikeln und Toner-Partikeln.
BG47198A3 (en) Method for extracting of glycopeptidic antibiotic
ES2071767T3 (es) Preparado estabilizado de microorganismos viables formadores de esporas, su produccion y comprimidos del mismo.
GB1181001A (en) A Process for the Production of Monomeric Cleavage Products by Thermally Degrading Polymers
DE69024392D1 (de) Verfahren zur Reinigung von Aussenmembran-Protein von Haemophilus influenza
ES478533A1 (es) Un procedimiento para eliminar melamina de liquidos que con-tienen melamina.
EP0611133A3 (en) Process of preparing an absorbable polymer.
EP0274533A4 (en) METHOD FOR PRODUCING NEURAMINIDASE.
DE69113344D1 (de) Verfahren zur Herstellung von faserverstärkten thermoplastischen Gegenständen und erhaltenes Produkt.
ES2176349T3 (es) Proceso de sililacion.
MX9806357A (es) Procesos para la produccion de particulas de poliacrilamida.
NO174588C (no) Fremgangsmåte for kontinuerlig fremstilling av ulike biotekniske produktgrupper ved anvendelse av kontinuerlig membranreaktor

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: INDUSTRIAL FARMACEUTICA CANTABRIA, S.A.

FD1A Patent lapsed

Effective date: 20000401